Study on the Efficacy and Safety of Gelaspan

Overview

It is the objective of the study to investigate the efficacy and safety of two different volume replacement regimens with gelatine solutions.

Full Title of Study: “Prospective Controlled Randomized Double-blind Multicentre Study in Parallel Groups on the Efficacy and Safety of Gelaspan in Combination With Sterofundin ISO in Comparison With Gelofusine in Combination With Sodium Chloride Braun in Patients Scheduled for Abdominal or Pelvic Surgery”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
  • Study Primary Completion Date: June 2017

Interventions

  • Drug: Gelaspan 4%
    • Gelaspan 4% combined with Sterofundin ISO
  • Drug: Gelofusine 4%
    • Gelofusine 4% combined with Sodium Chloride

Arms, Groups and Cohorts

  • Experimental: balanced gelatine solution
    • isotonic colloidal volume substitute
  • Active Comparator: non-balanced gelatine solution
    • colloidal volume substitute

Clinical Trial Outcome Measures

Primary Measures

  • Base Excess
    • Time Frame: Change in base excess from baseline to end of surgery

Secondary Measures

  • Base Excess
    • Time Frame: Change in base excess from baseline to 12 hours after end of surgery
  • Adverse events
    • Time Frame: until 12 hours after end of surgery
  • Hemodynamics
    • Time Frame: until 12 hours after end of surgery
  • Renal Function
    • Time Frame: until 12 hours after end of surgery
  • Arterial blood gas analysis
    • Time Frame: until 12 hours after end of surgery
  • Coagulation status
    • Time Frame: until 12 hours after end of surgery

Participating in This Clinical Trial

Inclusion:

  • Male or female patients ≥ 18 years of age and ≤ 80 years of age. – Patients scheduled to undergo open elective abdominal or pelvic surgery. – Anticipated intraoperative volume requirement for gelatine solution is at least 15 mL/kg body weight – Negative pregnancy test (urine dipsticks) in women of child bearing potential. – Provision of voluntary consent to participate in the study, following a full explanation of the nature and purpose of the study, by signing the informed consent form approved by the regulatory authorities of the Russian Federation and Local Ethics Committee (LEC) prior to all evaluations. Exclusion: – Patients of ASA-class > III. – Known hypersensitivity to gelatine or to any of the constituents of the solution. – Patients treated with other colloid solutions and / or blood products 24 hours prior to surgery. – Patients on hemodialysis. – Patients suffering from: – Decompensated renal function (i.e. serum creatinine > 3.0 mg/dL) – Hypervolemia; – Severe heart failure; – Moderate lung edema; – Hyperhydration; – Severe blood coagulation disorders (aPTT >2.5 x ULN or fibrinogen < 0.5 x LLN or INR >2.5 x ULN); – Hypernatremia (serum Na+ > 150 mmol/L); – Hyperchloremia (serum Cl- > 110 mmol/L); – Hypercalcemia (serum ionized Ca++ > 1.5 mmol/L); – Metabolic alkalosis; – Severe generalized edema; – Intracranial haemorrhage; – Hyperkalemia (serum K+ > 5.5 mmol/L). – Pregnancy and/or nursing. – Hypertension with the Systolic Blood Pressure > 180 mm Hg and Diastolic Blood Pressure > 110 mm Hg identified at screening. – Patients who in the investigator's opinion couldn't take part in the study. – Simultaneous participation in another clinical trial. – Emergencies.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • B. Braun Medical LLC
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.